Skip to content

The Impact of Glycemic Control on Rheumatoid Arthritis Disease Activity on Diabetic Patients

The Impact of Glycemic Control on Rheumatoid Arthritis Disease Activity in Diabetic Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06691997
Enrollment
100
Registered
2024-11-18
Start date
2024-12-12
Completion date
2027-06-01
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Rheumatoid Arthritis (RA

Keywords

glycemic control

Brief summary

The incidence of DM is unclear in RA but most prior data suggest that DM or insulin resistance in RA has risen because of activation of the immune system and/or RA therapy . Besides, RA causes joints to become stiff, swollen, and agonizing. As a result, the patient may not want to exercise or move. One study found that 42% of people with RA are not physically active. the aim of this study is To evaluate the glycemic status among RA patients with Type 2 diabetes and its association with disease activity.

Detailed description

Taking the potential link between DM and RA into consideration, detection and control of DM will significantly increase prolonged prognosis and therefore decrease the economic burden of RA patients and death rate. The aim of this research is to examine diabetic RA's glycemic status and to assess the relationship between RA and DM's clinical characteristics as well as the therapy response in RA patients with diagnosed DM. Keeping an eye on glycemic control in RA patients could prevent metabolic and cardiovascular comorbidities in those susceptible patients.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* type 2 diabetic patients * rheumatoid arthritis patients

Exclusion criteria

* gestional diabetes * type 1 diabetic patients

Design outcomes

Primary

MeasureTime frameDescription
Fasting blood glucosebaselinecorrelation between type 2 diabetes control and rheumatoid arthritis activity

Countries

Egypt

Contacts

Primary ContactAhmed khedr Nady
ahmed.16266234@med.aun.edu.eg+201097613616
Backup ContactEman Mohamed Ibrahim, Lecturer
emanmibrahem@aun.edu.eg+201007179120

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026